$CAPR
Price history, market instrument context, member research, and related headlines in one place.
CAPR key statistics
NasdaqGSUSD
52-week range
$2.9611%$40.37
Latest session $6.64–$7.33Capricor Therapeutics, Inc. (CAPR) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $7.26, down $0.01 (0.14%) from the previous close of $7.27. It has traded between $6.64 and $7.33 in the latest session. Over the past year it has ranged from $2.96 to $40.37, leaving it in the lower quarter of its 52-week range (11%). Reported volume for the session was 3.4M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Kaos Capital pushes for board changes at Capricor Therapeutics — See source for full details.
Capricor Therapeutics (CAPR) stock drops as Stat News warns the company
Why is Capricor Therapeutics stock surging today? — See source for full details.
Capricor surges on amended plans for lead drug; Cantor upgrades (update) — See source for full details.
Capricor outlines BLA amendment plan as FDA signals willingness to review, with PDUFA date set for August 22 — See source for full details.
Capricor Therapeutics (CAPR) Q2 earnings: GAAP EPS -$0.70 missed by $0.12; cash ~$238M as of June 30, 2026; shares +7.6%.
Capri beats top-line and bottom-line estimates; gives Q2 and updates FY26 outlook — See source for full details.
Loading $CAPR research…